Sumitomo Mitsui Trust Group
INDV icon

Sumitomo Mitsui Trust Group’s Indivior Pharmaceuticals INDV Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$470K Sell
15,420
-7,060
-31% -$233K ﹤0.01% 945
2025
Q4 		$807K Sell
22,480
-7,700
-26% -$235K ﹤0.01% 885
2025
Q3 		$728K Buy
+30,180
New +$632K ﹤0.01% 888

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sumitomo Mitsui Trust Group's INDV Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Indivior Pharmaceuticals (INDV) stake by 31% in Q1 2026, selling an estimated $233K and leaving 15,420 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

Sumitomo Mitsui Trust Group first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. The position peaked at $807K in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 15,420 shares of Indivior Pharmaceuticals worth $470K as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 7,060 Indivior Pharmaceuticals shares in Q1 2026, an estimated $233K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #945 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Sumitomo Mitsui Trust Group's Indivior Pharmaceuticals position peaked at $807K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.